Alteration of miR-21 and miR-24 expression: biomarker for early detection of synchronous metastases in colorectal cancer: a cross-sectional study in Indonesia [0.03%]
microRNA-21和microRNA-24表达的改变：印度尼西亚结直肠癌同步转移早期检测生物标志物的横断面研究
Yudith Annisa Ayu Rezkitha,Amal Arifi Hidayat,Irine Normalina et al.
Yudith Annisa Ayu Rezkitha et al.
Background/aims: Timely detection with highly accurate biomarkers would be helpful in effectively managing colorectal cancer (CRC). We aim to investigate the accuracy of 3 emerging biomarkers-miR-21, miR-24, and miR-145-i...
The role of the Mediterranean diet in the management of inflammatory bowel disease: a narrative review [0.03%]
地中海饮食在炎症性肠病管理中的作用：叙述性综述
Peter Vivian Acire,Stephanie C Brown,Andrew S Day
Peter Vivian Acire
Inflammatory bowel disease (IBD) is characterized by the presence of gastrointestinal inflammation, that in some individuals leads on to complications, including strictures. IBD can be associated with significant morbidity with disruption o...
Efficacy and safety of filgotinib in the treatment of ulcerative colitis with a focus on rapid and sustained efficacy: a narrative review [0.03%]
filgotinib治疗溃疡性结肠炎疗效和安全性的系统评价和meta分析（侧重快速及持续效应）
Tadakazu Hisamatsu,Toshihiko Kaise,Chisa Nagakura et al.
Tadakazu Hisamatsu et al.
The rising incidence of ulcerative colitis (UC) globally highlights the necessity for treatment strategies that extend beyond symptom control to include inducing and maintaining remission, achieving biochemical and endoscopic remission, and...
Ustekinumab-induced Henoch-Schönlein purpura in Crohn's disease: a case report and literature review [0.03%]
克罗恩病患者使用乌司奴单抗诱发亨诺赫-许伦登普尔综合征1例及相关文献复习
Merih Deniz Toruner,Tugce Guvenir,Volkan Yilmaz et al.
Merih Deniz Toruner et al.
Crohn's disease is a chronic inflammatory disease of the digestive tract with extraintestinal manifestations, which include skin conditions, arthritis, ocular inflammation, and several autoimmune conditions. Dermatologic manifestations in C...
Case Reports
Intestinal research. 2025 Nov 14. DOI:10.5217/ir.2025.00009 2025
Antinuclear antibodies seroconversion and endoscopic response to infliximab in biologic-naive Crohn's disease: a Chinese single-center, retrospective study [0.03%]
中国单中心生物制剂初治克罗恩病患者抗核抗体血清学转换与英夫利西单抗内镜疗效关系的回顾性研究
Jinlu Tong,Xitao Xu,Yuan Cao et al.
Jinlu Tong et al.
Background/aims: The development of antinuclear antibodies (ANAs) during infliximab treatment has been observed in previous clinical trials. To evaluate the clinical significance of ANA seroconversion and its potential as...
A survey on the practices and patterns in the management of acute severe ulcerative colitis in India [0.03%]
印度急性重症溃疡性结肠炎管理实践和模式的调查研究
Arshia Bhardwaj,Arshdeep Singh,Riya Sharma et al.
Arshia Bhardwaj et al.
Background/aims: The real-world management of acute severe ulcerative colitis (ASUC) varies considerably across regions and healthcare settings. This study aimed to evaluate current management practices for ASUC among gas...
The impact of inflammatory bowel disease on women's health: a cross sectional study in India [0.03%]
炎症性肠病对印度女性健康的影响：一项横断面研究
Arshia Bhardwaj,Arshdeep Singh,Riya Sharma et al.
Arshia Bhardwaj et al.
Background/aims: The gender-specific impact of inflammatory bowel disease (IBD) on women in low- and middle-income countries remains underexplored. We aimed to assess the effects of IBD on different domains of women's hea...
Optimizing Janus kinase inhibitor therapy for ulcerative colitis: a real-world perspective [0.03%]
溃疡性结肠炎Janus激酶抑制剂治疗的优化：真实世界视角
Shintaro Akiyama
Shintaro Akiyama
In real-world clinical practice, 3 Janus kinase (JAK) inhibitors-tofacitinib, filgotinib, and upadacitinib-are now available for the treatment of ulcerative colitis. Emerging real-world evidence highlights distinct efficacy and safety profi...
Treatment patterns and outcomes in patients with steroid-dependent ulcerative colitis in Japan: a claims database study [0.03%]
日本糖皮质激素依赖性溃疡性结肠炎患者的治疗模式和结局：基于理赔数据库的研究
Masayuki Saruta,Takumi Sugiyama,Takumi Tajima et al.
Masayuki Saruta et al.
Background/aims: Guidelines recommend that steroid treatment for ulcerative colitis (UC) is tapered or withdrawn within 3 months of initiation, and thiopurine treatment or advanced therapy is administered for steroid-depe...
Post-marketing surveillance of tofacitinib in patients with ulcerative colitis in Japan: a post hoc analysis of safety and effectiveness in older (≥65 years) and younger ( [0.03%]
托法替尼治疗溃疡性结肠炎患者上市后监测的后验安全性与疗效分析：老年（≥65 岁）和年轻（
Katsuyoshi Matsuoka,Takayuki Yamamoto,Minoru Matsuura et al.
Katsuyoshi Matsuoka et al.
Background/aims: To assess, post hoc, tofacitinib safety/effectiveness in patients with ulcerative colitis (UC), stratified by age, using data from a 60-week post-marketing surveillance (PMS) study in Japan. ...